chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 0.58
Sex: M
Vaccine: FLU3
Symptoms: Irritability, Pyrexia, Vaccination error
Clinical narrative: This non serious case was received on 24 February 2009 from a health care professional. A seven month old patient received second dose of FLUZONE (lot number UT283EA) on 13 February 2009. The patient received the first dose of FLUZONE (lot number unknown) on 23 January 2009. February 2009 the patient experienced a fever and was cranky. The patient went to the doctor's office on 24 February 2009 and did not have any symptoms at that time. The patient subsequently recovered. No further information was provided. List of documents held by sender: none
Sex: F
Vaccine: FLU3
Symptoms: Hypokinesia, Pain in extremity
Clinical narrative: Initital information was received on 16 October 2008 from a healthcare professional. A female patient with an allergy to Omnicef received a left deltoid injection of Fluzone on 02 October 2008. The patient reported that she had received twenty prior doses of Fluzone. On 02 October 2008 post vaccination, the patient developed left arm pain and was unable to lift her left arm over her head. No other symptoms were reported. The patient was not seen by a physician. The patient was not recovered at the time if the report.
Age: 45.0
Sex: M
Vaccine: FLU3
Symptoms: Chest discomfort, Oropharyngeal pain
Clinical narrative: A 45 year old male patient received an intramuscular right deltoid injection of FLUZONE (lot number U2847AA) on 21 October 2008 at 8:40 pm. Approximately four hours post vaccination at 8:00 PM, the patient developed chest tightness which lasted about an hour and also complained of a sore throat. The patient did not report any shortness of breath. The patient was not recovered at the time of the report. List of documents held by Sender: None.
Age: 47.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature normal, Chest discomfort, Cough, Sinus congestion
Clinical narrative: Tightness in chest, sinus congestion, dry cough. Initial report received from a healthcare professional in the United States on 21 October 2008. A 47-year old female patient experienced chest tightness, sinus congestion and dry cough within 45 minutes after receiving an intramuscular left deltoid injection of FLUZONE SV 2008-2009 (lot number U282AA). The patient was evaluated in the employee health department where her lungs were clear, oral temperature was 98.2 degrees Fahrenheit, blood pressure 128/78, pulse oximetry 96 and peak flow 270. TYLENOL was administered. The patient was advised to see her primary care physician. The patient reported this to be the third consecutive year that she experienced this exact reaction to FLUZONE, but she has never had it evaluated. At the time of the report, patient outcome was 'not recovered'. Follow-up information received on 14 November 2008 from a nurse in the United States. Per the reporter, the patient does not have an allergy to eggs or egg products. The patient was never evaluated by a physician for the adverse events reported above. the patient did not require any additional treatments for the above symptoms other than the TYLENOL that was previously reported. It was confirmed the patient was not diagnosed with an allergic reaction to the flu vaccine. The patient recovered in 2 days (date not provided). No further information is expected. Documents held by sender: None.
Age: 60.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site rash, Injection site vesicles, Pain
Clinical narrative: Initial report received on 23 October 2008 from a health professional. A 60 year old male patient, with no known allergies and a history of high cholesterol, received on 21 October 2008 a right deltoid intramuscular injection of FLUZONE (lot number U2749AA). Concomitant medications included Prostatin, Trazocine, and an unspecified cholesterol medication. The patient had no illness at the time of vaccination. On 22 October 2008, approximately 24 hours after vaccination, the patient noted an area around the injection site resembling ring worm with blisters. Additionally, a similar area was noted toward the back of the arm and the patient complained of pain (site not specified). At the time of the report, the patient had not recovered and was to be evaluated by a physician. Follow up information was received on 18 December 2008 from a health care professional. The patient required a doctor's visit, but did not have any laboratory tests or diagnostics completed. The patient did not received any vaccinations at the same time or within four weeks of FLUZONE. No other information was provided.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Cellulitis, Erythema, Local reaction, Oedema peripheral
Clinical narrative: Initial report received on 27 October 2008 from a health care professional. A 3 year-old male patient received on 22 October 2008 an intramuscular vaccination with Fluzone, into the left deltoid. A day after vaccination on 23 October 2008, the patient's arm was swollen. He was seen by a doctor on 27 October 2008, and was diagnosed with "significant local reaction, cellulitis of the left arm"' which was described as 4 inches long redness from shoulder to elbow. The patient was treated with KEFLEX and BENADRYL. The recovery status was unknown. Previous vaccinations were given on 2006-2007 and 2005. The patient had no allergies or medical conditions. The patient had no illness at vaccination time and he was not taking medications. Follow-up information received on 24 November 2008 from a health care professional. The patient had not received any other vaccination within four weeks of 22 October 2008. At the time of this report, the patient had recovered; however a recovery date was not provided.
Age: 35.0
Sex: M
Vaccine: FLU3
Symptoms: Arthralgia, Cold sweat, Headache, Insomnia, Pain
Clinical narrative: Cold sweat, sleeplessness, joint pain, headache. Initial report received 29 October 2008 from a consumer who is the patient. A 35 year old male patient with no past medical history, had received an intramuscular injection (site not reported) of FLUZONE SV 2008-2009, lot number U2883AA on 23 October 2008 and 8 hours later, he complained of cold sweats, joint pain and aches, headaches and sleeplessness. The event did not require evaluation by a health care professional. At the time of vaccination, the patient had no concurrent illnesses. He had not been taking any concomitant medications and he had no adverse events following vaccinations received in the past. The patient reported that he recovered from the event. No further information was provided at the time of the report. Follow-up information received on 26 January 2009 from a health care professional. The reporter clarified that the patient received FLUZONE (lot number U2833AA, previously reported as U2883AA) in the left deltoid. The patient stated that he recovered. No further information was provided at the time of the report. Follow-up information received 29 January 2009 from a health care professional who reported that the duration of the event had been 24 hours.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Discomfort, Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Joint range of motion decreased
Clinical narrative: Rotator cuff tenditnitis - Injected limb mobility decreased. Shoulder pain. Initial report received on 31 October 2008 from a healthcare professional in the United States. A 43 year old female, with a history of rheumatoid arthritis and unknown concomitant medications, received on 08 October 2008 a left deltoid intramuscular injection of FLUZONE (lot number U2832AA). She had no illness at the time of vaccination and had received no other vaccines in the previous four weeks. At the time of vaccination, the patient complained of pain. She continued to have a dull aching pain and one week later she began having difficulty abducting the left arm. At the time of the report, the symptoms were persisting. Follow-up information received from a health care professional on 21 November 2008. The patient had experienced immediate discomfort after the FLUZONE vaccination. Site of pain was confirmed to be the left shoulder with no radiation of pain. The patient continued to have constant left shoulder ache, pain with movements and limited range of motion in forward flexion due to pain. diagnosis was left rotator cuff tendinitis. Treatment included FLECTOR PATCH and six visits to physical therapy. As of 14 November 2008, the patient's condition showed improvement. Follow up information was received on 22 December 2008 from a health care professional in the USA. The patient had a history of hypothyroidism and gastroesophageal disease in addition to rheumatoid arthritis. The start date of the left rotator cuff tendonitis and pain were on 08 October 2008. The patient was medically evaluated on 04 November 2008. As of 15 December 2008 she was 90% improved. She completed six visits of physical therapy. She would occassionally use a LIDODERM PATCH and over the counter TYLENOL.  No further physician visits were needed. Documents held by sender: None.
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Musculoskeletal pain, Pain, Rotator cuff syndrome
Clinical narrative: Rotator cuff tenditnitis - Injected limb mobility decreased. Shoulder pain. Initial report received on 31 October 2008 from a healthcare professional in the United States. A 43 year old female, with a history of rheumatoid arthritis and unknown concomitant medications, received on 08 October 2008 a left deltoid intramuscular injection of FLUZONE (lot number U2832AA). She had no illness at the time of vaccination and had received no other vaccines in the previous four weeks. At the time of vaccination, the patient complained of pain. She continued to have a dull aching pain and one week later she began having difficulty abducting the left arm. At the time of the report, the symptoms were persisting. Follow-up information received from a health care professional on 21 November 2008. The patient had experienced immediate discomfort after the FLUZONE vaccination. Site of pain was confirmed to be the left shoulder with no radiation of pain. The patient continued to have constant left shoulder ache, pain with movements and limited range of motion in forward flexion due to pain. diagnosis was left rotator cuff tendinitis. Treatment included FLECTOR PATCH and six visits to physical therapy. As of 14 November 2008, the patient's condition showed improvement. Follow up information was received on 22 December 2008 from a health care professional in the USA. The patient had a history of hypothyroidism and gastroesophageal disease in addition to rheumatoid arthritis. The start date of the left rotator cuff tendonitis and pain were on 08 October 2008. The patient was medically evaluated on 04 November 2008. As of 15 December 2008 she was 90% improved. She completed six visits of physical therapy. She would occassionally use a LIDODERM PATCH and over the counter TYLENOL.  No further physician visits were needed. Documents held by sender: None.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Injection site induration, Muscular weakness, Pain in extremity, Pyrexia
Clinical narrative: Initial report received from a consumer on 03 November 2008. A 52-year-old female patient received a dose of FLUZONE SV 2008-2009 (lot number, route administration and number of previous doses not reported) to the left deltoid on 15 October 2008 and that same day, she developed arm soreness and redness that lasted approximately four days. On 23 October 2008, the patient received a dose of PNEUMOVAX (lot number, route of administration and number of previous doses not reported) to the right deltoid. Within 24 hours, the patient developed a fever of 102 degrees Fahrenheit, her arm became beet red, the veins in her chest were pronounced and the arm site became as hard as a rock. The patient also complained of muscle weakness which, at the time of the report, was almost completely resolved. Patient outcome was reported as 'not recovered'. Follow up information was received on 26 November 2008 from a health care professional. The patient received a dose of Fluzone SV 2008-2009 (lot number U2839AA) to the left deltoid on 15 October 2008. The number of previous doses received was reported as multiple. No further information was provided. Follow up information received on 02 January 2009 from a health care professional. The abbreviation for concomitant medication EES was confirmed to be erythromycin. Per the reporter, they did not see the patient after she received the Fluzone SV 2008-2009. Recovery status was not provided. No further information is expected.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Vasodilatation
Clinical narrative: Initial report received from a consumer on 03 November 2008. A 52-year-old female patient received a dose of FLUZONE SV 2008-2009 (lot number, route administration and number of previous doses not reported) to the left deltoid on 15 October 2008 and that same day, she developed arm soreness and redness that lasted approximately four days. On 23 October 2008, the patient received a dose of PNEUMOVAX (lot number, route of administration and number of previous doses not reported) to the right deltoid. Within 24 hours, the patient developed a fever of 102 degrees Fahrenheit, her arm became beet red, the veins in her chest were pronounced and the arm site became as hard as a rock. The patient also complained of muscle weakness which, at the time of the report, was almost completely resolved. Patient outcome was reported as 'not recovered'. Follow up information was received on 26 November 2008 from a health care professional. The patient received a dose of Fluzone SV 2008-2009 (lot number U2839AA) to the left deltoid on 15 October 2008. The number of previous doses received was reported as multiple. No further information was provided. Follow up information received on 02 January 2009 from a health care professional. The abbreviation for concomitant medication EES was confirmed to be erythromycin. Per the reporter, they did not see the patient after she received the Fluzone SV 2008-2009. Recovery status was not provided. No further information is expected.
Age: 32.0
Sex: F
Vaccine: FLU3
Symptoms: Abdominal discomfort, Pruritus, Rhinorrhoea
Clinical narrative: Initial non-serious report received from a health care professional on 04 November 2008. A 32 year-old female patient developed runny nose, itching and upset stomach one hour after receiving an intramuscular deltoid of FLUZONE. The symptoms lasted for four days. No additional details were provided. The reporter of this case is the same as cases 2008-03431 and 2008-03433. Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Basophil percentage decreased, Cough, Differential white blood cell count abnormal, Dyspnoea, Eosinophil percentage decreased
Clinical narrative: This serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 330782). A 46-year-old female patient, whose past medical history was not provided, had received on 30 October 2008 at 08:00 am an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2769AA). The site of administration was not provided. Approximately one and a half hours post-vaccination, the patient reported having a continuous dry cough and had developed rhinitis, red watery eyes, sore itchy throat, slight shortness of breath, soreness in her throat with breathing and coughing, especially with coughing. She returned to the clinic and was sent to the emergency room where a CBC w/diff was drawn. A saline lock was placed and the patient received a 1000cc bolus of normal saline. She was also treated with BENADRYL 25mg (IVP), DECADRON 4 mg (IVP) and SOLU-MEDROL 80mg (IVP). Lab results revealed CBC w/diff WBC 15.9 k/uL (increased), neutrophils 85%, (increased), bands 5%, lymphs 9% (increased), eosinophils 0% and basophiles 0%. The patient improved with treatment and was discharged to home in stable condition. The patient recovered (date not provided). Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Full blood count abnormal, Lacrimation increased, Lymphocyte percentage decreased, Monocyte percentage decreased, Neutrophil percentage increased
Clinical narrative: This serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 330782). A 46-year-old female patient, whose past medical history was not provided, had received on 30 October 2008 at 08:00 am an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2769AA). The site of administration was not provided. Approximately one and a half hours post-vaccination, the patient reported having a continuous dry cough and had developed rhinitis, red watery eyes, sore itchy throat, slight shortness of breath, soreness in her throat with breathing and coughing, especially with coughing. She returned to the clinic and was sent to the emergency room where a CBC w/diff was drawn. A saline lock was placed and the patient received a 1000cc bolus of normal saline. She was also treated with BENADRYL 25mg (IVP), DECADRON 4 mg (IVP) and SOLU-MEDROL 80mg (IVP). Lab results revealed CBC w/diff WBC 15.9 k/uL (increased), neutrophils 85%, (increased), bands 5%, lymphs 9% (increased), eosinophils 0% and basophiles 0%. The patient improved with treatment and was discharged to home in stable condition. The patient recovered (date not provided). Documents held by sender: None.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oropharyngeal pain, Rhinitis, Throat irritation
Clinical narrative: This serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 330782). A 46-year-old female patient, whose past medical history was not provided, had received on 30 October 2008 at 08:00 am an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2769AA). The site of administration was not provided. Approximately one and a half hours post-vaccination, the patient reported having a continuous dry cough and had developed rhinitis, red watery eyes, sore itchy throat, slight shortness of breath, soreness in her throat with breathing and coughing, especially with coughing. She returned to the clinic and was sent to the emergency room where a CBC w/diff was drawn. A saline lock was placed and the patient received a 1000cc bolus of normal saline. She was also treated with BENADRYL 25mg (IVP), DECADRON 4 mg (IVP) and SOLU-MEDROL 80mg (IVP). Lab results revealed CBC w/diff WBC 15.9 k/uL (increased), neutrophils 85%, (increased), bands 5%, lymphs 9% (increased), eosinophils 0% and basophiles 0%. The patient improved with treatment and was discharged to home in stable condition. The patient recovered (date not provided). Documents held by sender: None.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature normal, Chest discomfort, Erythema, Eye discharge, Eye pain
Clinical narrative: Wheezing. Tight chest. Bloodshot eye. Itchy eyes. Pain in eyes. Eye discharge. Eyes swollen.  Eyes red. Redness. Vomiting. Nausea. Ache. Productive cough. This non serious case was received on 24 February 2009 from VAERS (reference number 330523) via a search of QSCAN database. A 39 year old female patient received FLUZONE SV 2008-2009 intramuscularly (lot number U2762AA) on 22 October 2008 at 1:45 pm. The patient began feeling wheezy and had a tight chest at 3:00 pm. Temperature was 97.5. The patient did not have any shortness of breath and was able to continue normal activities. By 5:00 pm her eyes became extremely bloodshot, itchy, painful, and mucus filled. When pressing on her eyelids she noted copious amounts of yellow mucus. Her eyes became painful, swollen, and red. Her nose became red and she developed a productive cough. She took BENADRYL 25 mg and her symptoms became manageable. That night she had an episode of nausea and vomiting, and was achy. The next day she woke feeling better and had no signs or symptoms. The patient recovered.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Eye pruritus, Eye swelling, Nausea, Ocular hyperaemia, Pain
Clinical narrative: Wheezing. Tight chest. Bloodshot eye. Itchy eyes. Pain in eyes. Eye discharge. Eyes swollen.  Eyes red. Redness. Vomiting. Nausea. Ache. Productive cough. This non serious case was received on 24 February 2009 from VAERS (reference number 330523) via a search of QSCAN database. A 39 year old female patient received FLUZONE SV 2008-2009 intramuscularly (lot number U2762AA) on 22 October 2008 at 1:45 pm. The patient began feeling wheezy and had a tight chest at 3:00 pm. Temperature was 97.5. The patient did not have any shortness of breath and was able to continue normal activities. By 5:00 pm her eyes became extremely bloodshot, itchy, painful, and mucus filled. When pressing on her eyelids she noted copious amounts of yellow mucus. Her eyes became painful, swollen, and red. Her nose became red and she developed a productive cough. She took BENADRYL 25 mg and her symptoms became manageable. That night she had an episode of nausea and vomiting, and was achy. The next day she woke feeling better and had no signs or symptoms. The patient recovered.
Age: 39.0
Sex: F
Vaccine: FLU3
Symptoms: Productive cough, Vomiting, Wheezing
Clinical narrative: Wheezing. Tight chest. Bloodshot eye. Itchy eyes. Pain in eyes. Eye discharge. Eyes swollen.  Eyes red. Redness. Vomiting. Nausea. Ache. Productive cough. This non serious case was received on 24 February 2009 from VAERS (reference number 330523) via a search of QSCAN database. A 39 year old female patient received FLUZONE SV 2008-2009 intramuscularly (lot number U2762AA) on 22 October 2008 at 1:45 pm. The patient began feeling wheezy and had a tight chest at 3:00 pm. Temperature was 97.5. The patient did not have any shortness of breath and was able to continue normal activities. By 5:00 pm her eyes became extremely bloodshot, itchy, painful, and mucus filled. When pressing on her eyelids she noted copious amounts of yellow mucus. Her eyes became painful, swollen, and red. Her nose became red and she developed a productive cough. She took BENADRYL 25 mg and her symptoms became manageable. That night she had an episode of nausea and vomiting, and was achy. The next day she woke feeling better and had no signs or symptoms. The patient recovered.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Anxiety, Burning sensation, Dysphonia, Eye discharge, Eye pruritus
Clinical narrative: Anxiety. Ocular hyperaemia. Eye discharge. Eye pruritus. Feeling of warmth facial. Nasal congestion. Hoarse voice. Throat tightness. Throat irritation. Headache. This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference 330621). A 56 year old female patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2753AA) on 29 October 2008. Approximately one hour post-vaccination, she reported feeling like there was a golf ball in her throat, and felt anxious. Four and one-half hours later she developed red, glassy, and filmy eyes, facial burning, a sore and scratchy throat, nasal stuffiness, and a hoarse voice. At that time she took ibuprofen and TYLENOL, and reported to the employee health clinic where she was given CLARITIN and FLONASE. By 10 hours post-vaccination she continued to have scratchy eyes, a headache, stuffy nose, and yellow drainage from the eyes. All events subsequently recovered. Of note, the patient reported that "six years ago had MMR, and got Mumps/Measles".
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Headache, Nasal congestion, Ocular hyperaemia, Staring
Clinical narrative: Anxiety. Ocular hyperaemia. Eye discharge. Eye pruritus. Feeling of warmth facial. Nasal congestion. Hoarse voice. Throat tightness. Throat irritation. Headache. This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference 330621). A 56 year old female patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2753AA) on 29 October 2008. Approximately one hour post-vaccination, she reported feeling like there was a golf ball in her throat, and felt anxious. Four and one-half hours later she developed red, glassy, and filmy eyes, facial burning, a sore and scratchy throat, nasal stuffiness, and a hoarse voice. At that time she took ibuprofen and TYLENOL, and reported to the employee health clinic where she was given CLARITIN and FLONASE. By 10 hours post-vaccination she continued to have scratchy eyes, a headache, stuffy nose, and yellow drainage from the eyes. All events subsequently recovered. Of note, the patient reported that "six years ago had MMR, and got Mumps/Measles".
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Throat irritation, Throat tightness, Vision blurred
Clinical narrative: Anxiety. Ocular hyperaemia. Eye discharge. Eye pruritus. Feeling of warmth facial. Nasal congestion. Hoarse voice. Throat tightness. Throat irritation. Headache. This case was extracted from the VAERS database via QSCAN on 24 February 2009 (reference 330621). A 56 year old female patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2753AA) on 29 October 2008. Approximately one hour post-vaccination, she reported feeling like there was a golf ball in her throat, and felt anxious. Four and one-half hours later she developed red, glassy, and filmy eyes, facial burning, a sore and scratchy throat, nasal stuffiness, and a hoarse voice. At that time she took ibuprofen and TYLENOL, and reported to the employee health clinic where she was given CLARITIN and FLONASE. By 10 hours post-vaccination she continued to have scratchy eyes, a headache, stuffy nose, and yellow drainage from the eyes. All events subsequently recovered. Of note, the patient reported that "six years ago had MMR, and got Mumps/Measles".
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Eye irritation, Fatigue, Headache, Ocular hyperaemia
Clinical narrative: This case was extracted from the VAERS database via a search of QScan on 24 February 2009 (reference number 331690). A 33-year-old female patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2768AA) on 05 November 2008. Approximately five hours post-vaccination, she began experiencing fatigue, body aches and pains, bright red burning eyes, fever and lung tightness. She went to bed and subsequently began experiencing a headache approximately 12 hours post-vaccination. The following morning she had improved; red eyes continued.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Pain, Pyrexia
Clinical narrative: This case was extracted from the VAERS database via a search of QScan on 24 February 2009 (reference number 331690). A 33-year-old female patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2768AA) on 05 November 2008. Approximately five hours post-vaccination, she began experiencing fatigue, body aches and pains, bright red burning eyes, fever and lung tightness. She went to bed and subsequently began experiencing a headache approximately 12 hours post-vaccination. The following morning she had improved; red eyes continued.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Body temperature increased, Chest discomfort, Cough, Dysphonia, Eye pain
Clinical narrative: This non serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 333186). A 34-year-old female patient had received a first dose injection of FLUZONE SV 2008-2009 (route not reported), lot number U2739AA on 16 November 2008, and an unspecified amount of time later (reported as "at about 1:00pm), the patient developed a scratchy throat and red, watery, itchy eyes that felt like a film was covering her eyes. the patient had additional complaints of chest tightness and random "palpations" with her pulse faster than normal. She developed a cough due to a constant tickle in her throat, a dull constant headache (like pressure), aching in her entire body and she had no energy. These symptoms continued into the night and the patient was unable to sleep because of the headache and chest pressure (could not catch her breath). At 9:00 pm her temperature was measured at 99.7 degrees Fahrenheit. On the morning of 19 November 2008, the patient took 400 mg IBUPROFEN. She had no temperature (98.8), her chest was still tight, throat was hoarse, and her eyes were still runny, bloodshot and sore. These symptoms continued throughout the entire day with heart "palpations." At 2:00, the patient took another 400 mg of IBUPROFEN. On 20 November 2008, the patient woke up to normal white eyes, energy level was low, but more energy than previous days (11/18/ and 11/19). Heart "palpation" gone and throat was normal. The patient recovered from the even and felt no effects to date.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Eye pruritus, Fatigue, Headache, Insomnia, Lacrimation increased
Clinical narrative: This non serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 333186). A 34-year-old female patient had received a first dose injection of FLUZONE SV 2008-2009 (route not reported), lot number U2739AA on 16 November 2008, and an unspecified amount of time later (reported as "at about 1:00pm), the patient developed a scratchy throat and red, watery, itchy eyes that felt like a film was covering her eyes. the patient had additional complaints of chest tightness and random "palpations" with her pulse faster than normal. She developed a cough due to a constant tickle in her throat, a dull constant headache (like pressure), aching in her entire body and she had no energy. These symptoms continued into the night and the patient was unable to sleep because of the headache and chest pressure (could not catch her breath). At 9:00 pm her temperature was measured at 99.7 degrees Fahrenheit. On the morning of 19 November 2008, the patient took 400 mg IBUPROFEN. She had no temperature (98.8), her chest was still tight, throat was hoarse, and her eyes were still runny, bloodshot and sore. These symptoms continued throughout the entire day with heart "palpations." At 2:00, the patient took another 400 mg of IBUPROFEN. On 20 November 2008, the patient woke up to normal white eyes, energy level was low, but more energy than previous days (11/18/ and 11/19). Heart "palpation" gone and throat was normal. The patient recovered from the even and felt no effects to date.
Age: 34.0
Sex: F
Vaccine: FLU3
Symptoms: Myalgia, Ocular hyperaemia, Palpitations, Radial pulse increased, Throat irritation
Clinical narrative: This non serious case was extracted from the VAERS database via QScan on 24 February 2009 (reference number 333186). A 34-year-old female patient had received a first dose injection of FLUZONE SV 2008-2009 (route not reported), lot number U2739AA on 16 November 2008, and an unspecified amount of time later (reported as "at about 1:00pm), the patient developed a scratchy throat and red, watery, itchy eyes that felt like a film was covering her eyes. the patient had additional complaints of chest tightness and random "palpations" with her pulse faster than normal. She developed a cough due to a constant tickle in her throat, a dull constant headache (like pressure), aching in her entire body and she had no energy. These symptoms continued into the night and the patient was unable to sleep because of the headache and chest pressure (could not catch her breath). At 9:00 pm her temperature was measured at 99.7 degrees Fahrenheit. On the morning of 19 November 2008, the patient took 400 mg IBUPROFEN. She had no temperature (98.8), her chest was still tight, throat was hoarse, and her eyes were still runny, bloodshot and sore. These symptoms continued throughout the entire day with heart "palpations." At 2:00, the patient took another 400 mg of IBUPROFEN. On 20 November 2008, the patient woke up to normal white eyes, energy level was low, but more energy than previous days (11/18/ and 11/19). Heart "palpation" gone and throat was normal. The patient recovered from the even and felt no effects to date.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Cough, Hypoaesthesia oral, Lip swelling, Myalgia
Clinical narrative: Wheezing. Eye redness. Hypoesthesia oral. Lip swelling. Cough. Fever. Chills. Generalized muscle aches. This case was extracted from the VAERS database via a QSCAN search on 24 February 2009 (reference number 333768). A 53 year old male patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2748AA) on 15 October 2008. Within four hours post-vaccination, he began experiencing a cough with some mild wheezing. Within six hours post-vaccination, his upper lip became swollen and numb. By eight hours post-vaccination, he complained of extreme eye redness, fever, chills, and generalized aches. All symptoms resolved without treatment within 24 hours. Of note, the patient reported that he experienced fever and chills eight hours post-vaccination following flu vaccine "years ago". The patient had no food allergies, and had not eaten anything the evening after vaccination.
Age: 53.0
Sex: M
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Pyrexia, Wheezing
Clinical narrative: Wheezing. Eye redness. Hypoesthesia oral. Lip swelling. Cough. Fever. Chills. Generalized muscle aches. This case was extracted from the VAERS database via a QSCAN search on 24 February 2009 (reference number 333768). A 53 year old male patient received an intramuscular injection of FLUZONE SV 2008-2009 (lot number U2748AA) on 15 October 2008. Within four hours post-vaccination, he began experiencing a cough with some mild wheezing. Within six hours post-vaccination, his upper lip became swollen and numb. By eight hours post-vaccination, he complained of extreme eye redness, fever, chills, and generalized aches. All symptoms resolved without treatment within 24 hours. Of note, the patient reported that he experienced fever and chills eight hours post-vaccination following flu vaccine "years ago". The patient had no food allergies, and had not eaten anything the evening after vaccination.
Age: 32.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Cough, Fatigue, Headache, Myalgia
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 334709) via a search of the QSCAN database. A 32 year old male patient received Fluzone SV 2008-2009 (lot number U2741A) intramuscularly on 23 October 2008. On 24 October 2008 the patient developed blood shot eyes, a swollen throat, fever, chills, muscle aches sore throat, fatigue, cough, headache, and muscle aches. The patient was reported as recovered. No further information was provided. List of Documents held by sender: none.
Age: 32.0
Sex: M
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oropharyngeal pain, Pharyngeal oedema, Pyrexia
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 334709) via a search of the QSCAN database. A 32 year old male patient received Fluzone SV 2008-2009 (lot number U2741A) intramuscularly on 23 October 2008. On 24 October 2008 the patient developed blood shot eyes, a swollen throat, fever, chills, muscle aches sore throat, fatigue, cough, headache, and muscle aches. The patient was reported as recovered. No further information was provided. List of Documents held by sender: none.
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Chest discomfort, Conjunctivitis, Cough, Eye swelling, Oropharyngeal pain
Clinical narrative: Initial report extracted from VAERS via a QSCAN FDA report on 24 February 2009 (VAERS Identification number 334936). A 56-year-old male patient, whose past medical history was not provided, had received on 25 November 2008 a intramuscular injection of Fluzone SV 2008-2009 (lot number U2831AA). The route and site of administration was conjunctivitis, sore throat, non-productive cough, chest tightness, slight wheezes, swelling around the eyes and body aches. He self medicated with oral Benadryl 25 mg and oral Ibuprofen 200 mg twice a day with no effect. The patient recovered; however a recovery date was not provided. Documents held by sender: None
Age: 56.0
Sex: M
Vaccine: FLU3
Symptoms: Pain, Wheezing
Clinical narrative: Initial report extracted from VAERS via a QSCAN FDA report on 24 February 2009 (VAERS Identification number 334936). A 56-year-old male patient, whose past medical history was not provided, had received on 25 November 2008 a intramuscular injection of Fluzone SV 2008-2009 (lot number U2831AA). The route and site of administration was conjunctivitis, sore throat, non-productive cough, chest tightness, slight wheezes, swelling around the eyes and body aches. He self medicated with oral Benadryl 25 mg and oral Ibuprofen 200 mg twice a day with no effect. The patient recovered; however a recovery date was not provided. Documents held by sender: None
Age: 0.3
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC, RV5
Symptoms: Cough, Erythema, Nasal congestion, Pharyngeal erythema, Rhinorrhoea
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 336906) via a search of QScan database. A four month old female patient received FLUZONE SV 2008-2009, second dose of ROTATEQ, PREVNAR, PEDIARIX, and HAEMOPHILUS influenzae  type b (HIB) (manufacturer unknown) 02 October2008. On 18 July 2008 the patient was seen at the doctor's office for matting the left eye with redness for the two days and was treated with VIGAMOX on drop twice daily for five days both eyes. The patient had a small bony prominence redness noted. No irritability, nose congestion, and a red throat. The patient had a positive had a positive strep test. Lab showed the infant's white count elevated at 14.4 10^3/uL. She was treated with OMNICEF 125 mg per 3 cc, 3 cc, a day for 10 days. On 10 September 2008 the infant came to the doctor's office and noted to have nasal drainage and fussiness which she had for the past 2 days. She had a mild right ear effusion, sinusitis, and mild external swelling of the ear canal. She was treated with AMOXICILLIN 125 mg, 5 cc three times a day for ten days. The mother reported that on 10 October 2008 the infant was vaccinated with FLUZONE SV 2008-2009 administered in the right thigh. On 22 October 2008 she experienced non productive cough rhinorrhea but no sign of infection. Recovery status was not reported.
Age: 0.3
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, PNC, RV5
Symptoms: Streptococcal identification test positive, White blood cell count increased
Clinical narrative: This non serious case was received on 24 February 2009 from VAERS (reference number 336906) via a search of QScan database. A four month old female patient received FLUZONE SV 2008-2009, second dose of ROTATEQ, PREVNAR, PEDIARIX, and HAEMOPHILUS influenzae  type b (HIB) (manufacturer unknown) 02 October2008. On 18 July 2008 the patient was seen at the doctor's office for matting the left eye with redness for the two days and was treated with VIGAMOX on drop twice daily for five days both eyes. The patient had a small bony prominence redness noted. No irritability, nose congestion, and a red throat. The patient had a positive had a positive strep test. Lab showed the infant's white count elevated at 14.4 10^3/uL. She was treated with OMNICEF 125 mg per 3 cc, 3 cc, a day for 10 days. On 10 September 2008 the infant came to the doctor's office and noted to have nasal drainage and fussiness which she had for the past 2 days. She had a mild right ear effusion, sinusitis, and mild external swelling of the ear canal. She was treated with AMOXICILLIN 125 mg, 5 cc three times a day for ten days. The mother reported that on 10 October 2008 the infant was vaccinated with FLUZONE SV 2008-2009 administered in the right thigh. On 22 October 2008 she experienced non productive cough rhinorrhea but no sign of infection. Recovery status was not reported.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Conjunctivitis, Dyspnoea, Headache, Musculoskeletal stiffness, Nasal congestion
Clinical narrative: Conjunctivitis, eye blood shot. Neck rigid. Nasal inflammation. Dyspnea. Edema. Headache. Urticaria. Ache. This case was received on 11 March 2009 from VAERS (reference number 193014) via a search of the QSCAN database. A 48 year old female patient received FLUZONE (lot number U0920AA) on 23 October 2002. On that day the patient developed blood shot eyes, a headache, became achy, had difficulty breathing , and sinus swelling. The patient slept and developed hives on her face and a stiff neck. She was treated with BENADRYL. The patient's outcome was reported as emergency room or doctor's visit. No further information was provided.
Age: 48.0
Sex: F
Vaccine: FLU3
Symptoms: Ocular hyperaemia, Oedema, Pain, Urticaria
Clinical narrative: Conjunctivitis, eye blood shot. Neck rigid. Nasal inflammation. Dyspnea. Edema. Headache. Urticaria. Ache. This case was received on 11 March 2009 from VAERS (reference number 193014) via a search of the QSCAN database. A 48 year old female patient received FLUZONE (lot number U0920AA) on 23 October 2002. On that day the patient developed blood shot eyes, a headache, became achy, had difficulty breathing , and sinus swelling. The patient slept and developed hives on her face and a stiff neck. She was treated with BENADRYL. The patient's outcome was reported as emergency room or doctor's visit. No further information was provided.
Age: 4.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Cyanosis, Depressed level of consciousness, Dyskinesia, Gaze palsy, Oxygen saturation decreased
Clinical narrative: SHE FELL ASLEEP IN THE CAR - WHEN WOKE UP WAS CONFUSED - EYES GLAZED STARRING TO THE RIGHT COULDN'T TALK COMPLETE SENTECES, STARTING MUMBLING - COULDN'T TALK, MOVING MOUTH AND MAKING NOISES. TURNED AROUND TO TAKE TO ER - LABORED BREATHING - QUIT BREATHING AS THEY PULLED INTO THE ER AND WAS COMPLETELY UNRESPONSIVE - LIFE FLIGHTED TO SUNRISE MEDICAL
Age: 4.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Pallor, Posturing, Respiratory arrest
Clinical narrative: SHE FELL ASLEEP IN THE CAR - WHEN WOKE UP WAS CONFUSED - EYES GLAZED STARRING TO THE RIGHT COULDN'T TALK COMPLETE SENTECES, STARTING MUMBLING - COULDN'T TALK, MOVING MOUTH AND MAKING NOISES. TURNED AROUND TO TAKE TO ER - LABORED BREATHING - QUIT BREATHING AS THEY PULLED INTO THE ER AND WAS COMPLETELY UNRESPONSIVE - LIFE FLIGHTED TO SUNRISE MEDICAL
Age: 4.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Blood test, Computerised tomogram, Confusional state, Dyskinesia, Dyspnoea
Clinical narrative: SHE FELL ASLEEP IN THE CAR - WHEN WOKE UP WAS CONFUSED - EYES GLAZED STARRING TO THE RIGHT COULDN'T TALK COMPLETE SENTECES, STARTING MUMBLING - COULDN'T TALK, MOVING MOUTH AND MAKING NOISES. TURNED AROUND TO TAKE TO ER - LABORED BREATHING - QUIT BREATHING AS THEY PULLED INTO THE ER AND WAS COMPLETELY UNRESPONSIVE - LIFE FLIGHTED TO SUNRISE MEDICAL
Age: 4.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Electroencephalogram, Respiratory arrest, Somnolence, Speech disorder, Staring
Clinical narrative: SHE FELL ASLEEP IN THE CAR - WHEN WOKE UP WAS CONFUSED - EYES GLAZED STARRING TO THE RIGHT COULDN'T TALK COMPLETE SENTECES, STARTING MUMBLING - COULDN'T TALK, MOVING MOUTH AND MAKING NOISES. TURNED AROUND TO TAKE TO ER - LABORED BREATHING - QUIT BREATHING AS THEY PULLED INTO THE ER AND WAS COMPLETELY UNRESPONSIVE - LIFE FLIGHTED TO SUNRISE MEDICAL
Age: 4.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Unresponsive to stimuli
Clinical narrative: SHE FELL ASLEEP IN THE CAR - WHEN WOKE UP WAS CONFUSED - EYES GLAZED STARRING TO THE RIGHT COULDN'T TALK COMPLETE SENTECES, STARTING MUMBLING - COULDN'T TALK, MOVING MOUTH AND MAKING NOISES. TURNED AROUND TO TAKE TO ER - LABORED BREATHING - QUIT BREATHING AS THEY PULLED INTO THE ER AND WAS COMPLETELY UNRESPONSIVE - LIFE FLIGHTED TO SUNRISE MEDICAL
Age: 1.83
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Urticaria
Clinical narrative: Hives all over body. Benadryl PRN
Age: 23.0
Sex: M
Vaccine: PPV, FLU3, PPV
Symptoms: Body temperature increased, Heart rate increased, Hypertension, Injection site erythema
Clinical narrative: Report received from a nurse on 3-Nov-2009. A 23 year old male patient (date of birth 17-Sep-1986) received AFLURIA on 5-Oct-2009. PNEUMOVAX 23 intramuscularly in the right upper arm (0.5 ml, batch number 1134Y) was a co-suspect drug administered on 6-Oct-2009 for vaccination. The patient had a medical history of childhood asthma. On 7-Oct-2009 the patient developed chills and was taking TYLENOL. On 8-Oct-2009 the patient visited his health service and his temperature was observed to be 102.6 farenheit, his heart rate was 130, his right arm was red and his blood pressure elevated at 148/94. His EKG was a little abnormal and there was a depression in his ST. The patient was treated with intravenous BENADRYL then admitted to hospital from 8-Oct-2009 to 11-Oct-2009. The patient was diagnosed with cellulitis and treated with IV antibiotics. The patient recovered.
Age: 23.0
Sex: M
Vaccine: PPV, FLU3, PPV
Symptoms: Blood pressure increased, Body temperature increased, Cellulitis, Chills, Electrocardiogram ST segment depression
Clinical narrative: Report received from a nurse on 3-Nov-2009. A 23 year old male patient (date of birth 17-Sep-1986) received AFLURIA on 5-Oct-2009. PNEUMOVAX 23 intramuscularly in the right upper arm (0.5 ml, batch number 1134Y) was a co-suspect drug administered on 6-Oct-2009 for vaccination. The patient had a medical history of childhood asthma. On 7-Oct-2009 the patient developed chills and was taking TYLENOL. On 8-Oct-2009 the patient visited his health service and his temperature was observed to be 102.6 farenheit, his heart rate was 130, his right arm was red and his blood pressure elevated at 148/94. His EKG was a little abnormal and there was a depression in his ST. The patient was treated with intravenous BENADRYL then admitted to hospital from 8-Oct-2009 to 11-Oct-2009. The patient was diagnosed with cellulitis and treated with IV antibiotics. The patient recovered.
Age: 23.0
Sex: M
Vaccine: PPV, FLU3, PPV
Symptoms: Electrocardiogram abnormal, Heart rate increased, Injection site erythema
Clinical narrative: Report received from a nurse on 3-Nov-2009. A 23 year old male patient (date of birth 17-Sep-1986) received AFLURIA on 5-Oct-2009. PNEUMOVAX 23 intramuscularly in the right upper arm (0.5 ml, batch number 1134Y) was a co-suspect drug administered on 6-Oct-2009 for vaccination. The patient had a medical history of childhood asthma. On 7-Oct-2009 the patient developed chills and was taking TYLENOL. On 8-Oct-2009 the patient visited his health service and his temperature was observed to be 102.6 farenheit, his heart rate was 130, his right arm was red and his blood pressure elevated at 148/94. His EKG was a little abnormal and there was a depression in his ST. The patient was treated with intravenous BENADRYL then admitted to hospital from 8-Oct-2009 to 11-Oct-2009. The patient was diagnosed with cellulitis and treated with IV antibiotics. The patient recovered.
Age: 46.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Arthropod bite, Balance disorder, CSF protein normal, CSF white blood cell count negative, Condition aggravated
Clinical narrative: Numbness from the waist down. Develpoed shingles on leg 10/1/09. 11/19/09 DC summary and MR received for date 10/28/09.  DX: distal sensory neuropathy with dysesthesia. Presented w/ c/o 1 wk h/o progressive numbness/weakness of the bilat. LE. Flu vax given 10/1. SOB until 10/17. Numbness/weakness continued to worsen over a week, trouble w/ balance. Pt. states had shingles immed after flu vax and repeated exposure to tick bites. Several labs still pending at DC. Assessment: (+)weakness bilat. LE, gait instability w/ walking, (+)chronic mild HA.
Age: 46.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Gait disturbance, Herpes zoster, Hypoaesthesia, Immediate post-injection reaction, Lumbar puncture normal
Clinical narrative: Numbness from the waist down. Develpoed shingles on leg 10/1/09. 11/19/09 DC summary and MR received for date 10/28/09.  DX: distal sensory neuropathy with dysesthesia. Presented w/ c/o 1 wk h/o progressive numbness/weakness of the bilat. LE. Flu vax given 10/1. SOB until 10/17. Numbness/weakness continued to worsen over a week, trouble w/ balance. Pt. states had shingles immed after flu vax and repeated exposure to tick bites. Several labs still pending at DC. Assessment: (+)weakness bilat. LE, gait instability w/ walking, (+)chronic mild HA.